Molecular Diversity of Macrophages in Allergic Reaction: Comparison between the Allergenic Modes; Th1- and -Th2-Derived Immune Conditions
,
Abstract
Activated macrophages have been classified into classical (M1) and alternative (M2) macrophages. We aimed to establish a method to yield enough number of macrophages to analyze their molecular, biological and immunological functions. We used drugs; adjuvant albumin from chicken egg whites—Imject Alum (OVA- Alum) and OVA Complete Freund Adjuvant (OVA-CFA), to induce macrophages to M2 and M1 respectively.We analyzed the phenotype of purified macrophages induced under these immune conditions, using flow cytometry (FACS) to detect cell-surface molecules and the enzyme-linked immunosorbent assay (ELISA) was used to detect cytokines. The cDNA microarray was employed to measure changes in expression level of cell surface protein between M1 and M2 macrophages.Phenotype analysis of purified macrophages, induced under these immune conditions, showed macrophages induced by OVA-Alum was almost M2 while the proportion of M1 macrophages induced by OVA-CFA was significantly higher. The results also showed higher expression level of macrophage galactose N- acetyl-galactosamine specific lectin-2 protein (MGL1/2-PE), a known M2 macrophage marker, on the surface of Alum-induced macrophages. On the basis of these preliminary data, ELISA results revealed that after macrophage stimulation with lipopolysaccharides (LPS), the level of interleukin (IL)-10 produced by Alum- induced macrophages was higher than the level of IL-10 produced by CFA-induced macrophages. In contrast, the level of tumor necrosis factor-alpha (TNF-α) produced by CFA-induced macrophages was higher than Alum-induced macrophages.The cDNA microarray confirmed previous results and suggest immunoglobulin-like type 2 receptor alpha (Pilra) as a new marker for M1, macrophage galactose N-acetylgalactosamine-specific lectin 2 (Mgl2) as M2 macrophages marker.
1. Wan YY. Multi-tasking of helper T cells. Immunology 2010; 130(2):166-71.
2. Borek F, Silverstein AM, Gell PG. Delayed hypersensitivity to hapten-protein conjugates. III. saccharides as haptens. Proc Soc Exp Biol Med 1963;114:266-70.
3. Kitching AR, Holdsworth SR, Tipping PG. Crescentic glomerulonephritis-a manifestation of a nephritogenic Th1 response? HistolHistopathol 2000; 15(3):993-1003.
4. Gordon S. Alternative activation of macrophages. Nature Rev Immunol 2003; 3(1):23–35
5. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8(12):958-69.
6. Taubes G. Cancer prevention with a diabetes pill?Science 2012; 335(6064):29.
7. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010;32(5):593-604.
8. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003; 8(3):223-46.
9. Ebihara S, Kurachi H, Watanabe Y. A simple preparation method for mouse eosinophils and their responses to anti- allergic drug. Inflam Res 2007; 56(3):112–7.
10. Raes G, Brys L, Dahal BK, Brandt J, Grooten J, Brombacher F, et al. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J Leukoc Boil 2005; 77(3):321-7.
11. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent Thelper cell type 2 responses to inhaled antigen. J Exp Med 2002;196(12):1645-51
12. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012; 18(3):363-74.
13. Oh JY, Choi H, Lee RH, Roddy GW, Ylöstalo JH, Wawrousek E, et al. Identification of the HSPB4/TLR2/ NF-κB axis in macrophage as a therapeutic target for sterile inflammation of the cornea. EMBO Mol Med 2012; 4(5):435-48.
14. Ford AQ, Dasgupta P, Mikhailenko I, Smith EM, Noben- Trauth N, Keegan AD. Adoptive transfer of IL-4Rα+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. BMC Immunol 2012; 13:6.
15. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981; 11(10):805-15.
16. Fujisaka S, Usui I, Kanatani Y, Ikutani M, Takasaki I, Tsuneyama K, et al. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization inhigh-fat-fed mice. Endocrinology 2011;152(5):1789-99.
17. Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005; 115(4):433-40.
18. Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci U S A 2003; 100(8):4903-8.
19. Jaeger K, Paulsen F, Wohlrab J. Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin. Histochem Cell Biol 2008; 129(3):321-9.
20. Stacey M, Chang GW, Sanos SL, Chittenden LR, Stubbs L, Gordon S, et al. EMR4, a novel epidermal growth factor (EGF)-TM7 molecule up-regulated in activated mouse macrophages, binds to a putative cellular ligand on B lymphoma cell line A20. J Biol Chem 2002;277(32):29283-93
21. Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 2003; 278(20):18229-34.
22. Bobbie MW, Roy S, Trudeau K, Munger SJ, Simon AM, Roy S. Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. Invest Ophthalmol Vis Sci 2010; 51(7):3758-63.
23. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117(1):175–84.
24. Hamann J, Kwakkenbos MJ, de Jong EC, Heus H, Olsen AS, van Lier RA. Inactivation of the EGF-TM7 receptor EMR4 after the Pan-Homo divergence. Eur J Immunol 2003); 33(5):1365-71.
| Files | ||
| Issue | Vol 14, No 3 (2015) | |
| Section | Original Article(s) | |
| Keywords | ||
| Cell Markers Complete Freund Adjuvant Cytokines Hypersensitivity Inflammatory Macrophages Ovalbumin-alum Th1 cells Th2 cells | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
